Defibrillation is a critical intervention in the urgent treatment of life-threatening cardiac arrhythmias such as pulseless ventricular tachycardia (VT) and ventricular fibrillation (VF). Two main pad placement techniques are used:
- Anterior-Lateral Defibrillation (ALD) – the traditional first-line approach
- Vector Change Defibrillation (VC) – an alternative technique used when initial shocks are unsuccessful
Anterior-Lateral Defibrillation (ALD)
- Description: Pads are placed on the chest in a position that directs the electrical current across the heart muscle (myocardium).
- Role: This is the standard, first-line method in cardiac arrest scenarios.
- Strengths:
- Simple to apply
- Proven effective for initial resuscitation
- Recommended by resuscitation councils worldwide
Vector Change Defibrillation (VC)
- Description: The pad placement is altered to create a different electrical vector through the heart.
- When Used: Typically applied in refractory VF/VT cases, where standard ALD shocks have failed.
- Potential Benefits:
- May improve the success of defibrillation
- Can reduce the number of shocks required
- Has been associated with higher rates of return of spontaneous circulation (ROSC)
Clinical Significance
- ALD remains the go-to technique in most cardiac arrests due to its speed and ease of application.
- VC defibrillation is gaining recognition as a valuable alternative in difficult or refractory cases.
- Evidence suggests VC may improve outcomes, but further research is still needed to confirm its long-term benefits across different patient groups.
Key Considerations
- In hospital settings, trained teams may use VC defibrillation after multiple unsuccessful shocks.
- In pre-hospital settings (ambulance, first responders), ALD remains standard due to its simplicity and rapid application.
- The choice of technique should always prioritise speed, effectiveness, and patient safety.
Conclusion
While anterior-lateral defibrillation is the cornerstone of cardiac arrest management, vector change defibrillation offers an important alternative for refractory arrhythmias. Ongoing studies continue to refine best practices, with the goal of improving survival rates and neurological outcomes for patients experiencing VF or pulseless VT.